Taking people in ChinaNo phase
Multi-omics Research of Idopathic Normal Pressure Hydrocephalus (iNPH)
Key facts
- Where
- Hangzhou, ChinaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 60 and 90 years old?
Source: NCT04998175, who can take part
Where in China
- The second affliated hospital of zhejiang universityHangzhou, ChinaContact: Junming Zhu, M.DTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Trial code
- NCT04998175
- Record updated
- 24 April 2026
- Original description
The research is designed to study the prognostic factors of ventriculoperitoneal (VP) shunt for iNPH by multi-omics researchRead full original descriptionShow less
Multi-omics Research of Prognostic Factors of Ventriculoperitoneal Shunt for Idopathic Normal Pressure Hydrocephalus
The research is designed to study the prognostic factors of ventriculoperitoneal (VP) shunt for iNPH by multi-omics research
Inclusion: Age ≥ 60 years; Diagnosis of iNPH based on clinical assessment; Participant is able to give written informed consent.
Exclusion: Participant is not medically available for shunt surgery; Combining AD and Parkinson's disease and other nervous system diseases; Secondary NPH.